Until recently, there is only one report that focused on the role of SIK2 in EMT and tumor metastasis; that report demonstrated an inhibitory effect of SIK2 on migration and invasion of breast cancer cells by blocking EMT with simultaneous blockage of Ras/ERK and PI3K/AKT pathways [14]. Here, SIK2 is linked to neoplasm.